Voorbeelden van het gebruik van Tobi podhaler in het Engels en hun vertalingen in het Nederlands
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
How TOBI Podhaler works?
Other information about Tobi Podhaler.
How does Tobi Podhaler work?
TOBI Podhaler capsules must not be swallowed.
How much TOBI Podhaler to take?
TOBI Podhaler 28 mg inhalation powder, hard capsules.
Each weekly carton of TOBI Podhaler contains.
What TOBI Podhaler is used for?
No interaction studies have been performed with TOBI Podhaler.
How is Tobi Podhaler used?
FEV1 should be measured before and after inhalation of TOBI Podhaler.
How has Tobi Podhaler been studied?
adding another treatment to Tobi Podhaler.
Why has Tobi Podhaler been approved?
the disease is considered‘rare' and Tobi Podhaler was designated an‘orphan medicine'(a medicine used in rare diseases) on 17 March 2003.
What is Tobi Podhaler used for?
Cough was reported with use of TOBI Podhaler in clinical studies.
What TOBI Podhaler is and what it is used for?
When the patients in the placebo group were switched to Tobi Podhaler for the second and third cycles they also experienced a similar improvement in FEV1.
TOBI Podhaler is a powder for inhalation that is filled into capsules.
Always keep the TOBI Podhaler capsules in the capsule card.
Tobi Podhaler is a medicine that contains the active substance tobramycin.
The active substance in Tobi Podhaler, tobramycin, is an antibiotic that belongs to the group‘aminoglycosides.
TOBI Podhaler contains a medicine called tobramycin which is an antibiotic.
The effect of Tobi Podhaler was similar to that of Tobi after three cycles of treatment.
Tobi Podhaler is intended to increase the convenience of taking tobramycin for patients.
The full EPAR for Tobi Podhaler can be found on the Agency's website:
Tobi Podhaler is inhaled using a hand-held device called Podhaler. .
What TOBI Podhaler looks like and contents of the pack?
Tobi Podhaler was more effective than placebo in treating P. aeruginosa infection in patients with cystic fibrosis.
